Table 1 Open in new tab The detailed... | Oxford Academic

Table 1

Open in new tab

The detailed information of 13 cohorts used in our study. The first six cohorts are used for the five-fold-cross-validation experiment. The inflammatory bowel disease and ASD disease cohorts are used for cross study experiment.

Disease name	Cohort name	Disease cases	Healthy controls	Total number samples (TN)	Feature numbers	Imbalance Ratio (IR)	Reference
obesity	Obesity	164	89	253	465	1.84	[17, 43]
colorectal cancer	Colorectal	48	73	121	507	1.52	[17, 44]
liver cirrhosis	Cirrhosis	118	114	232	541	1.03	[17, 45]
Type 2 diabetes	EW-T2D	53	43	96	381	1.23	[17, 47]
Type 2 diabetes	C-T2D	170	174	344	606	1.02	[17, 46]
Inflammatory bowel disease	IBD	25	85	110	443	3.4	[17, 48]
	NielsenHB_2014	148	248	396	292	1.67	[16, 49]
	IjazUz_2017	56	38	94	230	1.34	[16, 50]
	ICDf	44	38	82	246	1.15	[30, 51]
Autism spectrum disorders	Li_ASD	120	401	521	1342	3.34	[52]
	Chen_ASD	76	47	123	455	1.61	[53]
	Arizo_ASD	20	20	40	841	1.0	[54]
	Dan_ASD	143	143	286	1120	1.0	[55]

Disease name	Cohort name	Disease cases	Healthy controls	Total number samples (TN)	Feature numbers	Imbalance Ratio (IR)	Reference
obesity	Obesity	164	89	253	465	1.84	[17, 43]
colorectal cancer	Colorectal	48	73	121	507	1.52	[17, 44]
liver cirrhosis	Cirrhosis	118	114	232	541	1.03	[17, 45]
Type 2 diabetes	EW-T2D	53	43	96	381	1.23	[17, 47]
Type 2 diabetes	C-T2D	170	174	344	606	1.02	[17, 46]
Inflammatory bowel disease	IBD	25	85	110	443	3.4	[17, 48]
	NielsenHB_2014	148	248	396	292	1.67	[16, 49]
	IjazUz_2017	56	38	94	230	1.34	[16, 50]
	ICDf	44	38	82	246	1.15	[30, 51]
Autism spectrum disorders	Li_ASD	120	401	521	1342	3.34	[52]
	Chen_ASD	76	47	123	455	1.61	[53]
	Arizo_ASD	20	20	40	841	1.0	[54]
	Dan_ASD	143	143	286	1120	1.0	[55]

Table 1

Open in new tab

The detailed information of 13 cohorts used in our study. The first six cohorts are used for the five-fold-cross-validation experiment. The inflammatory bowel disease and ASD disease cohorts are used for cross study experiment.

Disease name	Cohort name	Disease cases	Healthy controls	Total number samples (TN)	Feature numbers	Imbalance Ratio (IR)	Reference
obesity	Obesity	164	89	253	465	1.84	[17, 43]
colorectal cancer	Colorectal	48	73	121	507	1.52	[17, 44]
liver cirrhosis	Cirrhosis	118	114	232	541	1.03	[17, 45]
Type 2 diabetes	EW-T2D	53	43	96	381	1.23	[17, 47]
Type 2 diabetes	C-T2D	170	174	344	606	1.02	[17, 46]
Inflammatory bowel disease	IBD	25	85	110	443	3.4	[17, 48]
	NielsenHB_2014	148	248	396	292	1.67	[16, 49]
	IjazUz_2017	56	38	94	230	1.34	[16, 50]
	ICDf	44	38	82	246	1.15	[30, 51]
Autism spectrum disorders	Li_ASD	120	401	521	1342	3.34	[52]
	Chen_ASD	76	47	123	455	1.61	[53]
	Arizo_ASD	20	20	40	841	1.0	[54]
	Dan_ASD	143	143	286	1120	1.0	[55]

Disease name	Cohort name	Disease cases	Healthy controls	Total number samples (TN)	Feature numbers	Imbalance Ratio (IR)	Reference
obesity	Obesity	164	89	253	465	1.84	[17, 43]
colorectal cancer	Colorectal	48	73	121	507	1.52	[17, 44]
liver cirrhosis	Cirrhosis	118	114	232	541	1.03	[17, 45]
Type 2 diabetes	EW-T2D	53	43	96	381	1.23	[17, 47]
Type 2 diabetes	C-T2D	170	174	344	606	1.02	[17, 46]
Inflammatory bowel disease	IBD	25	85	110	443	3.4	[17, 48]
	NielsenHB_2014	148	248	396	292	1.67	[16, 49]
	IjazUz_2017	56	38	94	230	1.34	[16, 50]
	ICDf	44	38	82	246	1.15	[30, 51]
Autism spectrum disorders	Li_ASD	120	401	521	1342	3.34	[52]
	Chen_ASD	76	47	123	455	1.61	[53]
	Arizo_ASD	20	20	40	841	1.0	[54]
	Dan_ASD	143	143	286	1120	1.0	[55]